1. Home
  2. NRSN vs QMCO Comparison

NRSN vs QMCO Comparison

Compare NRSN & QMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • QMCO
  • Stock Information
  • Founded
  • NRSN 2017
  • QMCO 1980
  • Country
  • NRSN Israel
  • QMCO United States
  • Employees
  • NRSN N/A
  • QMCO N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • QMCO Electronic Components
  • Sector
  • NRSN Health Care
  • QMCO Technology
  • Exchange
  • NRSN Nasdaq
  • QMCO Nasdaq
  • Market Cap
  • NRSN 50.1M
  • QMCO 54.7M
  • IPO Year
  • NRSN 2021
  • QMCO N/A
  • Fundamental
  • Price
  • NRSN $1.06
  • QMCO $7.43
  • Analyst Decision
  • NRSN Buy
  • QMCO Hold
  • Analyst Count
  • NRSN 2
  • QMCO 2
  • Target Price
  • NRSN $14.00
  • QMCO $19.00
  • AVG Volume (30 Days)
  • NRSN 353.2K
  • QMCO 492.1K
  • Earning Date
  • NRSN 09-29-2025
  • QMCO 09-12-2025
  • Dividend Yield
  • NRSN N/A
  • QMCO N/A
  • EPS Growth
  • NRSN N/A
  • QMCO N/A
  • EPS
  • NRSN N/A
  • QMCO N/A
  • Revenue
  • NRSN N/A
  • QMCO $274,058,000.00
  • Revenue This Year
  • NRSN N/A
  • QMCO $7.49
  • Revenue Next Year
  • NRSN N/A
  • QMCO $3.22
  • P/E Ratio
  • NRSN N/A
  • QMCO N/A
  • Revenue Growth
  • NRSN N/A
  • QMCO N/A
  • 52 Week Low
  • NRSN $0.68
  • QMCO $2.22
  • 52 Week High
  • NRSN $2.60
  • QMCO $90.64
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 33.59
  • QMCO 44.48
  • Support Level
  • NRSN $1.05
  • QMCO $7.15
  • Resistance Level
  • NRSN $1.17
  • QMCO $7.79
  • Average True Range (ATR)
  • NRSN 0.12
  • QMCO 0.47
  • MACD
  • NRSN 0.01
  • QMCO 0.07
  • Stochastic Oscillator
  • NRSN 10.00
  • QMCO 56.44

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About QMCO Quantum Corporation

Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data. The company provides solutions for the entire data lifecycle. The company specialize in solutions for video, images, audio, and other large files. The company's portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The company's Primary Storage Software and Systems include Myriad All-Flash Software-Defined Storage, StorNext Hybrid Flash/Disk File Storage Software, and Unified Surveillance Platform Software. Secondary Storage Software and Systems include ActiveScale Object Storage Software and DXi Backup Appliances. The firm derives the majority of its revenue from United States.

Share on Social Networks: